{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"adult-polyglucosan-body-disease","columns":[{"gene":"","key":"population-e11a1d0ab0b16e273afd","label":"Polyglucosan body neuropathy, adult form","mondoId":"MONDO:0009897","onsetQualifier":null,"originColumnKey":"MONDO:0009897/OMIM:263570","originalViews":[{"key":"MONDO:0009897/OMIM:263570","label":"Polyglucosan body neuropathy, adult form","scopeLabel":"OMIM:263570","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0e6f6c5a6958f920392e1ece489c99922373f6dce044a0d521317d4b328af1ea","10a8f34a4787c328f4f1b8ff3b93a16a669aa840a5d4ceb2c46cb6725d4e4780","12758359f74ebaadf8466502a62ee349a583bef6c1aee7120b64e094589e9828","1d53bdc5ea61f63f5c22adcd252561f47e40f2a3f136af9b5d0a63a51605e6ce","1e8b081b1f1e15c408875dcf36d059ea348fe7b3a601a70758efb76f8da49747","23b2917cb737d90c6c851e803ad7b10001ec0b20dba626a05928b863031c4773","59c5eed4799fccd4a6d1dd5ba5d3bff9a3586225bf89d87338f940efd71af560","6dccfe05434bca06ad5f53010d7d7dfeaec370b1c0181842107e2b7039084653","9ba31ee86e10c67c56d6bae2e461326a9dd9435a76a70b68d6fc057b15a48c83","ad25fde3e3884ce42475ed9a59308fd065cd696b720a9139439e4901d759cd4a","af5de5300743b7b0b000c5ec0b0662553198517e115b0656176be35290eabb9a","de034962f0ba6361bd11badc1010a90808fc0b3f5d99aec87948b718b4e42023","e6a6a08cdee3dc0ba4c6a3e74d3d407aabd395e00c70e4f579653cf593e32d4e","f032d79e58459f77c74eb3511cf522fd0a3be6dfeabddba2ce8efc32fa2a8c08","fa8966f1f77cb2fd9ff2ce21246993c745d3c1a69b7efe45df031cb103e0e632"],"recordQualifiers":{},"scopeLabel":"OMIM:263570","sourceIds":["OMIM:263570"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-c7f193c78d3c4e1e8e2e","label":"Adult polyglucosan body disease","mondoId":"MONDO:0009897","onsetQualifier":null,"originColumnKey":"MONDO:0009897/ORPHA:206583","originalViews":[{"key":"MONDO:0009897/ORPHA:206583","label":"Adult polyglucosan body disease","scopeLabel":"ORPHA:206583","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["217141cd6ae896ecf54f114fb2c99dc7e68ab6a400fa146edfd2243dff20fa2e","224a17bfc97c78a14486fafb82ba7f6522a788f53071f1a0710f4e8d1108895d","465312fbde316c52d836bb9ccd2642142327620aa4246c2ad336949a4a58fd03","63aedbb65273ba636f6607a7f320e4ff86cd13301fb90bfe1f406b8dc2c2ae41","6c2584987e7a65bcf4f09068d980a5becea2b0264c1d891caa6b44a95d147c38","7510c57265a92cbd2fd85f180c903061aa3b49f50914641a8d9102ac8071271a","77a94d63ed15d5a5ad53362967ffc6445e1e282f816d4c96a579747e3f6fd5ea","77a9b44a14a344f766be3ffc4bef438803888cfd23649f43dd4ee88ea1c61285","7a527b1173e0b026cbdb052e95a4df2680b6fa2da66cb712ed3e078baf0a407c","7cfbd364377fbc0f1840dd784c529650e414cc2575c7e1426d73eab7348afd2c","84afbc0165f594f0917934e219b1d8c191d875066c0079b18f14718feccebfa7","863affce27062e8f72bfd350b9a2daf29d2a5723d50b7784ff8da7790e0ffa89","9c0cf4ddf9a582de2c1c849361f0cf28fe3a0a913b8e6bd0ce90ae2efdc5d5e7","b8a3ceab19f025f9199675b17951b1980598390bb1b5412a541ebc67192fc8bf","bc730eabd8c1742a6ae7e8cb9dcfa3ad570e4c91a2a433b51d737c83f2f0337b","d328825cdb35e6d8418172cab1007d8f8386b8d288d57512ebf3d05252bcf83d","e1168b2d919285aab04efec42ff837d109b7011bc7cbe673de40003c7e007895","e5eccf260d0939c230d1a1d47b3cbbb8cad913b93a9bd9695b86c20e00b1d662"],"recordQualifiers":{},"scopeLabel":"ORPHA:206583","sourceIds":["ORPHA:206583"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-e11a1d0ab0b16e273afd","population-c7f193c78d3c4e1e8e2e"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002500","HP:0007256","HP:0002127","HP:0002071","HP:0003438","HP:0001251","HP:0000708"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":9,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":33,"sourceGroups":{"omim":6,"orphanet":18,"published":9}},"features":[{"hpoId":"HP:0002500","label":"Abnormal cerebral white matter morphology","primary":true},{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0002127","label":"Abnormal upper motor neuron morphology","primary":true},{"hpoId":"HP:0002071","label":"Abnormality of extrapyramidal motor function","primary":true},{"hpoId":"HP:0003438","label":"Absent Achilles reflex","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":false},{"hpoId":"HP:0000726","label":"Dementia","primary":false},{"hpoId":"HP:0002936","label":"Distal sensory impairment","primary":false},{"hpoId":"HP:0003457","label":"EMG abnormality","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0001269","label":"Hemiparesis","primary":false},{"hpoId":"HP:0002922","label":"Increased CSF protein concentration","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0001376","label":"Limitation of joint mobility","primary":false},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0000011","label":"Neurogenic bladder","primary":false},{"hpoId":"HP:0001278","label":"Orthostatic hypotension","primary":false},{"hpoId":"HP:0003401","label":"Paresthesia","primary":false},{"hpoId":"HP:0003477","label":"Peripheral axonal neuropathy","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0200042","label":"Skin ulcer","primary":false},{"hpoId":"HP:0001258","label":"Spastic paraplegia","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0002273","label":"Tetraparesis","primary":false},{"hpoId":"HP:0002839","label":"Urinary bladder sphincter dysfunction","primary":false},{"hpoId":"HP:0000020","label":"Urinary incontinence","primary":false}],"ledeHtml":"Adult polyglucosan body disease (APBD) is a condition that affects the nervous system. People with APBD typically first experience signs and symptoms related to the condition between ages 35 and 60. Initial symptoms of the disorder include numbness and tingling in the legs (peripheral neuropathy) and progressive muscle weakness and stiffness (spasticity). As a result, affected individuals can have an unsteady gait, poor balance, and an increased risk of falling.","mondoId":"MONDO:0009897","node":{"canonicalSlug":"adult-polyglucosan-body-disease","comparisons":[{"documentSha256":"caff253b5031801a7c2f1062643b45d5f9f19ded187f5dd3f48c6210e8dcd641","key":"legacy-glycogen-storage-disease-type-iv","kind":"legacy","label":"glycogen storage disease due to glycogen branching enzyme deficiency","memberIds":["MONDO:0009292","MONDO:0009897"],"mondoId":"MONDO:0009292","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/glycogen-storage-disease-type-iv.caff253b5031801a7c2f1062643b45d5f9f19ded187f5dd3f48c6210e8dcd641.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["Mutations in the GBE1 gene cause APBD. The GBE1 gene provides instructions for making the glycogen branching enzyme. This enzyme is involved in the production of a complex sugar called glycogen, which is a major source of stored energy in the body. Most GBE1 gene mutations that cause APBD result in a shortage (deficiency) of the glycogen branching enzyme, which leads to the production of abnormal glycogen molecules. These abnormal glycogen molecules, called polyglucosan bodies, accumulate within cells and cause damage. Nerve cells (neurons) appear to be particularly vulnerable to the accumulation of polyglucosan bodies in people with this disorder, leading to impaired neuronal function.","Some mutations in the GBE1 gene that cause APBD do not result in a shortage of glycogen branching enzyme. In people with these mutations, the activity of this enzyme is normal. How mutations cause the disease in these individuals is unclear. Other people with APBD do not have identified mutations in the GBE1 gene. In these individuals, the cause of the disease is unknown."],"causesUrl":"https://medlineplus.gov/genetics/condition/adult-polyglucosan-body-disease/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"Adult polyglucosan body disease","paragraphs":["Adult polyglucosan body disease (APBD) is a condition that affects the nervous system. People with APBD typically first experience signs and symptoms related to the condition between ages 35 and 60. Initial symptoms of the disorder include numbness and tingling in the legs (peripheral neuropathy) and progressive muscle weakness and stiffness (spasticity). As a result, affected individuals can have an unsteady gait, poor balance, and an increased risk of falling.","Damage to the nerves that control bladder function, a condition called neurogenic bladder, is another feature that often occurs early in the course of APBD. Affected individuals have increasing difficulty starting or stopping the flow of urine.","Eventually, most people with APBD lose the ability to control their bladder and bowel functions and their limbs. Damage to the autonomic nervous system, which controls body functions that are mostly involuntary, leads to problems with blood pressure, heart rate, breathing rate, digestion, temperature regulation, and sexual response, and results in daily bouts of exhaustion. About half of people with APBD experience a decline in intellectual function (dementia)."],"reviewed":"2013-02","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/adult-polyglucosan-body-disease"},"ownColumnKeys":["population-e11a1d0ab0b16e273afd","population-c7f193c78d3c4e1e8e2e"],"publication":"published","relationships":[{"kind":"parent","label":"glycogen storage disease due to glycogen branching enzyme deficiency","mondoId":"MONDO:0009292","slug":"glycogen-storage-disease-type-iv"},{"kind":"parent","label":"hereditary peripheral neuropathy","mondoId":"MONDO:0020127","slug":"hereditary-peripheral-neuropathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/108","pageMondoId":"MONDO:0009897","source":"GARD","name":"Adult polyglucosan body disease","url":"https://rarediseases.info.nih.gov/diseases/108","relationToPage":"same-condition","coveredMondoIds":["MONDO:0009897"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-25T03:38:09Z","upstream":"GARD:0000108","rawAttribution":"MONDO:0009897","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"reported","key":"0e6f6c5a6958f920392e1ece489c99922373f6dce044a0d521317d4b328af1ea","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003477","is_excluded":false,"label":"Peripheral axonal neuropathy","onset_id":null,"reference":"OMIM:263570","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"10a8f34a4787c328f4f1b8ff3b93a16a669aa840a5d4ceb2c46cb6725d4e4780","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0000020","is_excluded":false,"label":"Urinary incontinence","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"12758359f74ebaadf8466502a62ee349a583bef6c1aee7120b64e094589e9828","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002127","is_excluded":false,"label":"Abnormal upper motor neuron morphology","onset_id":null,"reference":"OMIM:263570","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"1d53bdc5ea61f63f5c22adcd252561f47e40f2a3f136af9b5d0a63a51605e6ce","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0001258","is_excluded":false,"label":"Spastic paraplegia","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"1e8b081b1f1e15c408875dcf36d059ea348fe7b3a601a70758efb76f8da49747","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002500","is_excluded":false,"label":"Abnormal cerebral white matter morphology","onset_id":null,"reference":"OMIM:263570","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"217141cd6ae896ecf54f114fb2c99dc7e68ab6a400fa146edfd2243dff20fa2e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000011","is_excluded":false,"label":"Neurogenic bladder","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"224a17bfc97c78a14486fafb82ba7f6522a788f53071f1a0710f4e8d1108895d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002936","is_excluded":false,"label":"Distal sensory impairment","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"23b2917cb737d90c6c851e803ad7b10001ec0b20dba626a05928b863031c4773","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001278","is_excluded":false,"label":"Orthostatic hypotension","onset_id":null,"reference":"OMIM:263570","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"465312fbde316c52d836bb9ccd2642142327620aa4246c2ad336949a4a58fd03","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"59c5eed4799fccd4a6d1dd5ba5d3bff9a3586225bf89d87338f940efd71af560","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"1/7","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"63aedbb65273ba636f6607a7f320e4ff86cd13301fb90bfe1f406b8dc2c2ae41","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003457","is_excluded":false,"label":"EMG abnormality","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c2584987e7a65bcf4f09068d980a5becea2b0264c1d891caa6b44a95d147c38","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6dccfe05434bca06ad5f53010d7d7dfeaec370b1c0181842107e2b7039084653","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002273","is_excluded":false,"label":"Tetraparesis","onset_id":null,"reference":"OMIM:263570","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7510c57265a92cbd2fd85f180c903061aa3b49f50914641a8d9102ac8071271a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001376","is_excluded":false,"label":"Limitation of joint mobility","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"77a94d63ed15d5a5ad53362967ffc6445e1e282f816d4c96a579747e3f6fd5ea","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000020","is_excluded":false,"label":"Urinary incontinence","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"77a9b44a14a344f766be3ffc4bef438803888cfd23649f43dd4ee88ea1c61285","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7a527b1173e0b026cbdb052e95a4df2680b6fa2da66cb712ed3e078baf0a407c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002071","is_excluded":false,"label":"Abnormality of extrapyramidal motor function","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7cfbd364377fbc0f1840dd784c529650e414cc2575c7e1426d73eab7348afd2c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001269","is_excluded":false,"label":"Hemiparesis","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"84afbc0165f594f0917934e219b1d8c191d875066c0079b18f14718feccebfa7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"863affce27062e8f72bfd350b9a2daf29d2a5723d50b7784ff8da7790e0ffa89","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"9ba31ee86e10c67c56d6bae2e461326a9dd9435a76a70b68d6fc057b15a48c83","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9c0cf4ddf9a582de2c1c849361f0cf28fe3a0a913b8e6bd0ce90ae2efdc5d5e7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ad25fde3e3884ce42475ed9a59308fd065cd696b720a9139439e4901d759cd4a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"af5de5300743b7b0b000c5ec0b0662553198517e115b0656176be35290eabb9a","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000011","is_excluded":false,"label":"Neurogenic bladder","onset_id":null,"reference":"OMIM:263570","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b8a3ceab19f025f9199675b17951b1980598390bb1b5412a541ebc67192fc8bf","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002839","is_excluded":false,"label":"Urinary bladder sphincter dysfunction","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc730eabd8c1742a6ae7e8cb9dcfa3ad570e4c91a2a433b51d737c83f2f0337b","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0200042","is_excluded":false,"label":"Skin ulcer","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d328825cdb35e6d8418172cab1007d8f8386b8d288d57512ebf3d05252bcf83d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"de034962f0ba6361bd11badc1010a90808fc0b3f5d99aec87948b718b4e42023","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0002922","is_excluded":false,"label":"Increased CSF protein concentration","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e1168b2d919285aab04efec42ff837d109b7011bc7cbe673de40003c7e007895","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e5eccf260d0939c230d1a1d47b3cbbb8cad913b93a9bd9695b86c20e00b1d662","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206583","disease_name":"Adult polyglucosan body disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:206583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e6a6a08cdee3dc0ba4c6a3e74d3d407aabd395e00c70e4f579653cf593e32d4e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0002936","is_excluded":false,"label":"Distal sensory impairment","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f032d79e58459f77c74eb3511cf522fd0a3be6dfeabddba2ce8efc32fa2a8c08","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0003401","is_excluded":false,"label":"Paresthesia","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fa8966f1f77cb2fd9ff2ce21246993c745d3c1a69b7efe45df031cb103e0e632","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:263570","disease_name":"Polyglucosan body neuropathy, adult form","evidence":"PCS","frequency_raw":"6/7","hpo_id":"HP:0003438","is_excluded":false,"label":"Absent Achilles reflex","onset_id":null,"reference":"PMID:9851430","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/adult-polyglucosan-body-disease\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/108\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009897\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Adult polyglucosan body disease (APBD) is a condition that affects the nervous system. People with APBD typically first experience signs and symptoms related to the condition between ages 35 and 60. Initial symptoms of the disorder include numbness and tingling in the legs (peripheral neuropathy) and progressive muscle weakness and stiffness (spasticity). As a result, affected individuals can have an unsteady gait, poor balance, and an increased risk of falling.</p><p>Damage to the nerves that control bladder function, a condition called neurogenic bladder, is another feature that often occurs early in the course of APBD. Affected individuals have increasing difficulty starting or stopping the flow of urine.</p><p>Eventually, most people with APBD lose the ability to control their bladder and bowel functions and their limbs. Damage to the autonomic nervous system, which controls body functions that are mostly involuntary, leads to problems with blood pressure, heart rate, breathing rate, digestion, temperature regulation, and sexual response, and results in daily bouts of exhaustion. About half of people with APBD experience a decline in intellectual function (dementia).</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/adult-polyglucosan-body-disease\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Mutations in the GBE1 gene cause APBD. The GBE1 gene provides instructions for making the glycogen branching enzyme. This enzyme is involved in the production of a complex sugar called glycogen, which is a major source of stored energy in the body. Most GBE1 gene mutations that cause APBD result in a shortage (deficiency) of the glycogen branching enzyme, which leads to the production of abnormal glycogen molecules. These abnormal glycogen molecules, called polyglucosan bodies, accumulate within cells and cause damage. Nerve cells (neurons) appear to be particularly vulnerable to the accumulation of polyglucosan bodies in people with this disorder, leading to impaired neuronal function.</p><p>Some mutations in the GBE1 gene that cause APBD do not result in a shortage of glycogen branching enzyme. In people with these mutations, the activity of this enzyme is normal. How mutations cause the disease in these individuals is unclear. Other people with APBD do not have identified mutations in the GBE1 gene. In these individuals, the cause of the disease is unknown.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/adult-polyglucosan-body-disease/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"adult-polyglucosan-body-disease","sourceDocuments":[{"name":"MedlinePlus: Adult polyglucosan body disease","reviewed":"2013-02","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/adult-polyglucosan-body-disease"},{"name":"GARD: Adult polyglucosan body disease","reviewed":null,"source_release":"2026-10-25T03:38:09Z","url":"https://rarediseases.info.nih.gov/diseases/108"},{"name":"MONDO: adult polyglucosan body disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009897"}],"sourceNote":"","synonyms":["APBD","APBN","polyglucosan body disease, adult","polyglucosan body neuropathy, adult form"],"takeawayHtml":"","title":"adult polyglucosan body disease"},"schemaVersion":1}
